UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

JAMA surgery, 2019-11, Vol.154 (11), p.1038

2019

Volltextzugriff (PDF)

Biliary tract cancers: current knowledge, clinical candidates and future challenges

Cancer management and research, 2019-03, Vol.11, p.2623-2642

2019

Volltextzugriff (PDF)

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-09, Vol.304 (10), p.1073

2010

Volltextzugriff (PDF)

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

JAMA : the journal of the American Medical Association, 2012-07, Vol.308 (2), p.147

2012

Volltextzugriff (PDF)

POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study

Value in health, 2022-01, Vol.25 (1), p.S218-S219

2022

Volltextzugriff (PDF)

Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

Value in health, 2017-10, Vol.20 (9), p.A422

2017

Volltextzugriff (PDF)

PCN59 - Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

Value in health, 2017-10, Vol.20 (9), p.A422-A422

2017

Volltextzugriff (PDF)

Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours

Clinical endocrinology (Oxford), 2016-03, Vol.84 (3), p.348-352

2016

Volltextzugriff (PDF)

Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume

Journal of clinical oncology, 2005-02, Vol.23 (5), p.973-981

2005

Volltextzugriff (PDF)

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes

Cancer management and research, 2019-08, Vol.11, p.7537-7556

2019

Volltextzugriff (PDF)

The Discursive Practice of Learning Disability: Implications for Instruction and Parent—School Relations

Journal of learning disabilities, 2004-11, Vol.37 (6), p.466-481

2004

Volltextzugriff (PDF)

Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery

Surgical oncology, 2016-09, Vol.25 (3), p.223-228

2016

Volltextzugriff (PDF)

ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

JOURNAL OF CLINICAL ONCOLOGY, 2016, Vol.34 (18_suppl), p.LBA4006-LBA4006

2016

Volltextzugriff (PDF)

Dynamical left-right symmetry breaking

Physical review. D, Particles and fields, 1996-03, Vol.53 (5), p.2752-2780

1996

Volltextzugriff (PDF)

Efficacy and safety of telotristat etiprate in patients with carcinoid syndrome not adequately controlled by somatostatin analog therapy: Analysis of the ongoing TELESTAR extension period

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

British journal of cancer, 2005-02, Vol.92 (4), p.628-630

2005

Volltextzugriff (PDF)

IDEA and Collaboration: A Bakhtinian Perspective on Parent and Professional Discourse

Journal of learning disabilities, 2002-09, Vol.35 (5), p.469-479

2002

Volltextzugriff (PDF)

PCN171 IDENTIFYING STRUCTURAL UNCERTAINTY IN ECONOMIC MODELS OF CANCER TREATMENTS: A CASE STUDY OF IRINOTECAN IN COLORECTAL CANCER (CRC)

Value in health, 2009, Vol.12 (7), p.A289-A290

2009

Volltextzugriff (PDF)

Why hasn't the National Institute been 'NICE' to patients with colorectal cancer?

British journal of cancer, 2002-06, Vol.86 (11), p.1667-1669

2002

Volltextzugriff (PDF)

A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?

Pancreas, 2006-01, Vol.32 (1), p.51-57

2006

Volltextzugriff (PDF)

Adjuvant therapy for gastric cancer - has the standard changed?

British journal of cancer, 2001-04, Vol.84 (7), p.875-877

VALLE, J. W

2001

Volltextzugriff (PDF)

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer

British journal of cancer, 2003-04, Vol.88 (7), p.1153-1154

2003

Volltextzugriff (PDF)

Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor

Journal of cancer research and clinical oncology, 2006, Vol.132 (1), p.41-44

2006

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(54)
Tagungsberichte
(3)

Sprache

Englisch
(57)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(41)
Humans
(24)
Biological And Medical Sciences
(22)
Male
(16)
Middle Aged
(14)
Aged
(13)
Female
(13)
Adult
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Medical Sciences
(12)
Oncology
(12)
Medicin Och Hälsovetenskap
(11)
Physical Sciences
(9)
Tumors
(7)
Agriculture
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Astronomy & Astrophysics
(6)
Chemotherapy
(6)
Physics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

Biliary tract cancers: current knowledge, clinical candidates and future challenges

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study

Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

PCN59 - Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up

Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours

Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes

The Discursive Practice of Learning Disability: Implications for Instruction and Parent—School Relations

Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery

ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Dynamical left-right symmetry breaking

Efficacy and safety of telotristat etiprate in patients with carcinoid syndrome not adequately controlled by somatostatin analog therapy: Analysis of the ongoing TELESTAR extension period

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

IDEA and Collaboration: A Bakhtinian Perspective on Parent and Professional Discourse

PCN171 IDENTIFYING STRUCTURAL UNCERTAINTY IN ECONOMIC MODELS OF CANCER TREATMENTS: A CASE STUDY OF IRINOTECAN IN COLORECTAL CANCER (CRC)

Why hasn't the National Institute been 'NICE' to patients with colorectal cancer?

A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?

Adjuvant therapy for gastric cancer - has the standard changed?

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer

Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor

Suchergebnisse filtern